New nerve block combo could cut opioid use after thyroid surgery

NCT ID NCT07274670

Completed Symptom relief Sponsor: Udayana University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether adding dexmedetomidine to a standard nerve block (superficial cervical plexus block) improves pain control after thyroid surgery. Fifty-eight adults undergoing thyroid surgery were randomly assigned to receive the nerve block with or without dexmedetomidine. The main goal was to see how long it took before patients needed pain medication and how much opioid painkiller they used in the first 24 hours.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Dexmedetomidine and Bupivacaine
What this could lead to: If it works, this could lead to better pain control and less reliance on opioids after thyroid surgery.
What could go wrong: This is a small, completed trial with only 58 participants. Results may not apply to everyone, and there is a risk of side effects like slow heart rate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GOITER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain goiter hyperthyroidism Pain, Postoperative thyroid cancer Thyroid Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GOITER HYPERTHYROIDISM THYROID CANCER

Contacts and locations

Locations

Prof. Dr. I.G.N.G Ngoerah Central General Hospital

Denpasar, Bali, 80114, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.